PNV 1.24% $2.38 polynovo limited

I still don't understand how the Novosorb provides long term...

  1. 221 Posts.
    lightbulb Created with Sketch. 90
    I still don't understand how the Novosorb provides long term hernia repair if it is absorbed into the body? There must be a heightened chance of the hernia reoccurring when compared to a permanent mesh. The article Sojourner references indicates this:
    'Nevertheless, after prosthesis absorption, the resulting scar tissue is not as strong as it was, and alone is insufficient to provide the needed strength and could result in hernia recurrence.'

    Yes there are some problems with permanent mesh as well so it becomes a trade-off, but I'm not clear how Novosorb will take the hernia market by storm if Doctors are not confident that the new method provides a long term solution? Even if it is just the perception that absorbable mesh doesn't provide as good a long term solution, won't it take years to generate the evidence to prove that the perception is wrong? I haven't seen this answered by Polynovo anywhere?

 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.38
Change
-0.030(1.24%)
Mkt cap ! $1.642B
Open High Low Value Volume
$2.42 $2.44 $2.36 $4.288M 1.798M

Buyers (Bids)

No. Vol. Price($)
4 28177 $2.37
 

Sellers (Offers)

Price($) Vol. No.
$2.38 26895 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.